Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

Woo G, Tomlinson G, Nishikawa Y, Kowgier M, Sherman M, Wong DK, Pham B, Ungar WJ, Einarson TR, Heathcote EJ, Krahn M.

Gastroenterology. 2010 Oct;139(4):1218-29. doi: 10.1053/j.gastro.2010.06.042. Epub 2010 Jun 20. Review.

PMID:
20600036
[PubMed - indexed for MEDLINE]
2.

Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

Dienstag JL, Wei LJ, Xu D, Kreter B.

Clin Drug Investig. 2007;27(1):35-49. Review.

PMID:
17177578
[PubMed - indexed for MEDLINE]
3.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

PMID:
16904047
[PubMed - indexed for MEDLINE]
Free Article
4.

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.

Jones J, Colquitt J, Shepherd J, Harris P, Cooper K.

Health Technol Assess. 2010 May;14 Suppl 1:23-9. doi: 10.3310/hta14Suppl1/04. Review.

PMID:
20507800
[PubMed - indexed for MEDLINE]
Free Article
5.

Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis.

Zhao P, Liu W, Zhao J, Guan Q.

Virol J. 2011 Feb 22;8:75. doi: 10.1186/1743-422X-8-75. Review.

PMID:
21342505
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.

PMID:
11982721
[PubMed - indexed for MEDLINE]
7.

Entecavir for the treatment of chronic hepatitis B infection.

Shepherd J, Gospodarevskaya E, Frampton G, Cooper K.

Health Technol Assess. 2009 Oct;13 Suppl 3:31-6. doi: 10.3310/hta13suppl3/05. Review.

PMID:
19846026
[PubMed - indexed for MEDLINE]
Free Article
8.

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.

Sheng YJ, Liu JY, Tong SW, Hu HD, Zhang DZ, Hu P, Ren H.

Virol J. 2011 Aug 8;8:393. doi: doi:10.1186/1743-422X-8-393. Review.

PMID:
21824397
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Management of chronic hepatitis B.

Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.

Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Review.

PMID:
19408969
[PubMed - indexed for MEDLINE]
Free Article
10.

Treatment of chronic hepatitis B: Evolution over two decades.

Yuen MF, Lai CL.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:138-43. doi: 10.1111/j.1440-1746.2010.06545.x. Review.

PMID:
21199525
[PubMed - indexed for MEDLINE]
11.

Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients.

Hadziyannis SJ.

Expert Opin Investig Drugs. 2007 Jun;16(6):777-86. Review.

PMID:
17501691
[PubMed - indexed for MEDLINE]
12.

Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion.

Lau GK.

Liver Int. 2010 Apr;30(4):512-20. doi: 10.1111/j.1478-3231.2009.02198.x. Epub 2010 Jan 19. Review.

PMID:
20102511
[PubMed - indexed for MEDLINE]
13.

[Interferon in hepatitis B].

García Buey L, González Mateos F, Moreno Otero R.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:19-31. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100228
[PubMed - indexed for MEDLINE]
14.

Entecavir versus lamivudine for the treatment of chronic hepatitis B: a systematic review.

Liang J, Tang YF, Wu FS, Deng X.

Pharmazie. 2012 Nov;67(11):883-90. Review.

PMID:
23210236
[PubMed - indexed for MEDLINE]
15.

New developments in the treatment of chronic hepatitis B.

Hadziyannis SJ.

Expert Opin Biol Ther. 2006 Sep;6(9):913-21. Review.

PMID:
16918258
[PubMed - indexed for MEDLINE]
16.

Current pharmacotherapy for the treatment of chronic hepatitis B.

Lagget M, Rizzetto M.

Expert Opin Pharmacother. 2003 Oct;4(10):1821-7. Review.

PMID:
14521491
[PubMed - indexed for MEDLINE]
17.

Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.

Leung N.

Liver Int. 2011 Jan;31 Suppl 1:85-9. doi: 10.1111/j.1478-3231.2010.02387.x. Review.

PMID:
21205143
[PubMed - indexed for MEDLINE]
18.

Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

Shamliyan TA, MacDonald R, Shaukat A, Taylor BC, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL, Wilt TJ.

Ann Intern Med. 2009 Jan 20;150(2):111-24. Epub 2009 Jan 5. Review.

PMID:
19124812
[PubMed - indexed for MEDLINE]
19.

Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

Buster EH, Schalm SW, Janssen HL.

Best Pract Res Clin Gastroenterol. 2008;22(6):1093-108. doi: 10.1016/j.bpg.2008.11.007. Review.

PMID:
19187869
[PubMed - indexed for MEDLINE]
20.

Economic evaluation of treatments for chronic hepatitis B.

Wiens A, Lenzi L, Venson R, Pedroso ML, Correr CJ, Pontarolo R.

Braz J Infect Dis. 2013 Jul-Aug;17(4):418-26. doi: 10.1016/j.bjid.2012.12.005. Epub 2013 Jul 10. Review.

PMID:
23849851
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk